Obesity influences the outcomes of anti-IgE (omalizumab) therapy of asthma. Gu C, Upchurch K, Mamaril-Davis J, Wiest M, et al. Clin Exp Allergy 2020 Jun 25. doi: 10.1111/cea.13696.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gu C, Upchurch K, Mamaril-Davis J, Wiest M, et al. Obesity influences the outcomes of anti-IgE (omalizumab) therapy of asthma. Clin Exp Allergy 2020 Jun 25. doi: 10.1111/cea.13696.
PMID: 32585057